Table 4. Interaction between selected miRNAs and target genes in different pathways (DIANA-mirPath v.2).

miRNAs	p Value	Gene Target
Pathways in cancer (hsa05200)
hsa-miR-200a-3p	0.006320485	TCF7L1, CTNNB1
hsa-miR-182-5p	0.01027914	MITF, EP300, CDKN1A, FOXO1
hsa-miR-99a-5p	0.006069299	FGFR3, MTOR
hsa-miR-145-5p	0.000288274	IGF1R, TPM3, MMP1, MYC, CDKN1A, STAT1
hsa-miR-214-3p	0.03587201	TP53, MAPK8, DAPK1, PTEN
Bladder cancer (hsa05219)
hsa-miR-99a-5p	0.005785765	FGFR3
hsa-miR-100-5p	0.005422842	FGFR3
hsa-miR-145-5p	0.000288274	MMP1, MYC, CDKN1A
hsa-miR-214-3p	0.00565335	TP53, DAPK1
Adherens junction (hsa04520)
hsa-miR-200a-3p	1.30E–06	TCF7L1, WASF3, CTNNB1
PI3K-Akt signaling pathway (hsa04151)
hsa-miR-99a-5p	0.005785765	FGFR3, MTOR
hsa-miR-100-5p	0.04890642	FGFR3
MAPK signaling pathway (hsa04010)
hsa-miR-100-5p	0.03917171	FGFR3
hsa-miR-214-3p	0.002472282	MAP2K5, MAP2K3, TP53, RASA1, MAPK8